PRME SG&A Expense Growth

Prime Medicine Inc · SG&A Expense Growth

PRME logo

PRME SG&A Expense Growth

Latest reported4.36%
PRME FY SG&A Growth (YoY) (0.00% → 4.36%)
High-resolution chart · PNG

PRME sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Prime Medicine Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
4.356%
15.613%
45.5012%
114.1554%
340.3542%
152.5559%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.